Multidose Archives - World Asthma Foundation

December 5, 2016

Study of Fluticasone Propionate Multidose Dry Powder Inhaler Compared With Fluticasone Propionate/Salmeterol Multidose Dry Powder Inhaler

Condition: Asthma
Interventions: Drug: Fp MDPI; Drug: FS MDPI; Drug: Placebo
Sponsor: Teva Branded Pharmaceutical Products, R&D Inc.
Not yet recruiting – verified November 2016

View full post on ClinicalTrials.gov: asthma | Studies received in the last 14 days

November 23, 2016

A Study to Evaluate the Relationship Between Use of Albuterol Electronic Multidose Dry Powder Inhaler (eMDPI) and Exacerbations in Patients With Asthma

Condition: Asthma
Intervention: Drug: ABS eMDPI
Sponsor: Teva Branded Pharmaceutical Products, R&D Inc.
Not yet recruiting – verified November 2016

View full post on ClinicalTrials.gov: asthma | Studies received in the last 14 days

July 14, 2015

Randomized, Placebo-controlled, Multi-dose, Study Comparing Budesonide/Formoterol to Symbicort® in Asthmatic Patients

Condition: Asthma
Interventions: Drug: Symbicort; Drug: Generic Budesonide/Formoterol fumarate dihydrate; Drug: Placebo
Sponsor: Actavis Inc.
Not yet recruiting – verified July 2015

View full post on ClinicalTrials.gov: asthma | received in the last 14 days

July 7, 2014

Long-Term Safety Study of Fluticasone Propionate (Fp) Multidose Dry Powder Inhaler (MDPI) and Fluticasone Propionate/Salmeterol (FS) MDPI in Patients With Persistent Asthma

Condition: Persistent Asthma
Interventions: Drug: Fluticasone propionate Multidose Dry Powder Inhaler (Fp MDPI); Drug: Fluticasone propionate /salmeterol MDPI (FS MDPI); Drug: Fluticasone propionate HFA Inhalation Aerosol; Drug: Fluticasone propionate/salmeterol dry powder formulation
Sponsors: Teva Pharmaceutical Industries; Teva Branded Pharmaceutical Products, R&D Inc.
Recruiting – verified June 2014

View full post on ClinicalTrials.gov: asthma | received in the last 14 days